Further analysis by RT-qPCR confirmed the E/N-cadherin switch, the decrease of TJ markers, and of CK14 whose downregulation was recently shown to mark an advanced mesenchymal state in melanoma and breast tumors18, and also the decrease of the mammary differentiation marker CD49f (Fig. 5b). The gene discussed is CDH2; the disease is melanoma.